{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T05:36:57Z","timestamp":1740807417389,"version":"3.38.0"},"reference-count":11,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,12]],"date-time":"2024-12-12T00:00:00Z","timestamp":1733961600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eNeurologicalSci"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.ensci.2024.100545","type":"journal-article","created":{"date-parts":[[2024,12,15]],"date-time":"2024-12-15T04:15:50Z","timestamp":1734236150000},"page":"100545","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Deterioration of preexisting myoclonus following nifedipine use in parkinsonian syndrome: A case report"],"prefix":"10.1016","volume":"38","author":[{"given":"Gohei","family":"Yamada","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takanari","family":"Toyoda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eiichi","family":"Katada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noriyuki","family":"Matsukawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ensci.2024.100545_bb0005","doi-asserted-by":"crossref","first-page":"154","DOI":"10.7326\/0003-4819-103-1-154_1","article-title":"Verapamil and myoclonic dystonia","volume":"103","author":"Hicks","year":"1985","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ensci.2024.100545_bb0010","doi-asserted-by":"crossref","first-page":"125","DOI":"10.7326\/0003-4819-104-1-125_2","article-title":"Nifedipine and myoclonic dystonia","volume":"104","author":"de Medina","year":"1986","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ensci.2024.100545_bb0015","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1159\/000185303","article-title":"Nifedipine and myoclonic disorders","volume":"51","author":"Pedro-Botet","year":"1989","journal-title":"Nephron"},{"key":"10.1016\/j.ensci.2024.100545_bb0020","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.2146\/ajhp100704","article-title":"Myoclonus associated with long-term use of diltiazem","volume":"68","author":"Swanoski","year":"2011","journal-title":"Am. J. Health Syst. Pharm."},{"key":"10.1016\/j.ensci.2024.100545_bb0025","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1212\/WNL.58.6.984","article-title":"Multifocal myoclonus due to verapamil overdose","volume":"58","author":"Vadlamudi","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.ensci.2024.100545_bb0030","first-page":"447","article-title":"Diltiazem-induced myoclonus","volume":"92","author":"Jeret","year":"1992","journal-title":"N Y State J. Med."},{"key":"10.1016\/j.ensci.2024.100545_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.amjmed.2008.10.036","article-title":"Amlodipine-induced myoclonus","volume":"122","author":"Wallace","year":"2009","journal-title":"Am. J. Med."},{"key":"10.1016\/j.ensci.2024.100545_bb0040","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1097\/00002826-199510000-00004","article-title":"Effects of calcium antagonists on the dopamine system","volume":"18","author":"Mena","year":"1995","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.ensci.2024.100545_bb0045","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/0091-3057(94)00389-Z","article-title":"Effects of isradipine and darodipine on serotonergic system of the rat brain","volume":"51","author":"Gaggi","year":"1995","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ensci.2024.100545_bb0050","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/sj.bjp.0702574","article-title":"The effects of verapamil and diltiazem on N-, P- and Q-type calcium channels mediating dopamine release in rat striatum","volume":"127","author":"Dobrev","year":"1999","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ensci.2024.100545_bb0055","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/j.1365-2125.1988.tb03307.x","article-title":"Age-related changes in the pharmacokinetics and pharmacodynamics of nifedipine","volume":"25","author":"Robertson","year":"1988","journal-title":"Br. J. Clin. Pharmacol."}],"container-title":["eNeurologicalSci"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405650224000522?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405650224000522?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T15:05:29Z","timestamp":1740755129000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405650224000522"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":11,"alternative-id":["S2405650224000522"],"URL":"https:\/\/doi.org\/10.1016\/j.ensci.2024.100545","relation":{},"ISSN":["2405-6502"],"issn-type":[{"type":"print","value":"2405-6502"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Deterioration of preexisting myoclonus following nifedipine use in parkinsonian syndrome: A case report","name":"articletitle","label":"Article Title"},{"value":"eNeurologicalSci","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ensci.2024.100545","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100545"}}